- Home
- BIVI vs PHH Comparison
BIVI vs PHH Comparison
Compare BIVI & PHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- PHH
- Stock Information
- Founded
- BIVI 2013
- PHH 2016
- Country
- BIVI United States
- PHH China
- Employees
- BIVI N/A
- PHH N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- PHH Package Goods/Cosmetics
- Sector
- BIVI Health Care
- PHH Consumer Discretionary
- Exchange
- BIVI Nasdaq
- PHH Nasdaq
- Market Cap
- BIVI 14.2M
- PHH 16.2M
- IPO Year
- BIVI N/A
- PHH 2024
- Fundamental
- Price
- BIVI $1.91
- PHH $0.38
- Analyst Decision
- BIVI
- PHH
- Analyst Count
- BIVI 0
- PHH 0
- Target Price
- BIVI N/A
- PHH N/A
- AVG Volume (30 Days)
- BIVI 184.5K
- PHH 370.4K
- Earning Date
- BIVI 11-12-2025
- PHH 08-26-2025
- Dividend Yield
- BIVI N/A
- PHH N/A
- EPS Growth
- BIVI N/A
- PHH N/A
- EPS
- BIVI N/A
- PHH N/A
- Revenue
- BIVI N/A
- PHH $2,768,120.00
- Revenue This Year
- BIVI N/A
- PHH N/A
- Revenue Next Year
- BIVI N/A
- PHH N/A
- P/E Ratio
- BIVI N/A
- PHH N/A
- Revenue Growth
- BIVI N/A
- PHH 42.65
- 52 Week Low
- BIVI $1.42
- PHH $0.36
- 52 Week High
- BIVI $75.00
- PHH $41.49
- Technical
- Relative Strength Index (RSI)
- BIVI 46.41
- PHH 25.94
- Support Level
- BIVI $1.81
- PHH $0.38
- Resistance Level
- BIVI $2.07
- PHH $0.43
- Average True Range (ATR)
- BIVI 0.13
- PHH 0.03
- MACD
- BIVI 0.03
- PHH 0.06
- Stochastic Oscillator
- BIVI 37.99
- PHH 9.01
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.